Unknown

Dataset Information

0

Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist.

ABSTRACT: The blockade of aberrant hedgehog (Hh) signaling has shown promise for therapeutic intervention in cancer. A cell-based phenotypic high-throughput screen was performed, and the lead structure (1) was identified as an inhibitor of the Hh pathway via antagonism of the Smoothened receptor (Smo). Structure-activity relationship studies led to the discovery of a potent and specific Smoothened antagonist N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide (5m, NVP-LDE225), which is currently in clinical development.

SUBMITTER: Pan S 

PROVIDER: S-EPMC4007689 | biostudies-literature | 2010 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The blockade of aberrant hedgehog (Hh) signaling has shown promise for therapeutic intervention in cancer. A cell-based phenotypic high-throughput screen was performed, and the lead structure (1) was identified as an inhibitor of the Hh pathway via antagonism of the Smoothened receptor (Smo). Structure-activity relationship studies led to the discovery of a potent and specific Smoothened antagonist N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carbox  ...[more]

Similar Datasets

Unknown NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivo.
| S-EPMC3728309 | biostudies-literature
Unknown Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma.
| S-EPMC5430394 | biostudies-literature
Unknown Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia.
| S-EPMC4860619 | biostudies-literature
Unknown Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist.
| S-EPMC4018154 | biostudies-literature
Unknown Identification of a potent antagonist of smoothened in hedgehog signaling.
| S-EPMC7923671 | biostudies-literature
Unknown Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist.
| S-EPMC4018168 | biostudies-literature
Unknown Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist.
| S-EPMC4018059 | biostudies-literature
Unknown Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 Activity.
| S-EPMC4007949 | biostudies-literature
Unknown Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.
| S-EPMC4025788 | biostudies-other
Unknown Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma.
| S-EPMC6047040 | biostudies-literature